Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” third-quarter 2025 investor letter. A ...

DexCom showed strong growth, margin expansion, and Stelo's OTC launch unlocked new markets despite competitive and regulatory ...

If you’re trying to figure out whether now’s the time to buy, hold, or even sell DexCom stock, you’re not alone. After all, its share price has been a bit of a roller coaster lately. Over the last ...

DexCom › One way to earn above-average market returns -- which isn't always easy -- is to invest in companies that have lagged the market but are likely to recover over the long run. As the basic ...

DexCom (NASDAQ:DXCM) stock saw a notable increase of 16% on Friday following the announcement of its Q1 earnings and a share buyback program. The company’s first-quarter sales hit $1.04 billion, ...

Medtech leaders with varying degrees of experience have offered a range of advice in terms of leadership at the helm of a ...

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by ...

DexCom is one of the leaders in an industry with massive growth potential. The company is building a competitive advantage. Despite several risks, it could deliver substantial returns in the long run.

With the Ryder Cup is in the rearview mirror, Paige Spiranac is finding ways to keep golf fans entertainted. Spiranac, 32, ...

More details about a possible deal in the media industry contributed to another leg up for Paramount and Warner Bros Discovery, while a report from a short seller sent shares of DexCom sharply lower.